1,265
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Adherence to treatment guidelines and good asthma control in Finland

ORCID Icon, , , & ORCID Icon
Article: 2149918 | Received 13 Jan 2021, Accepted 17 Nov 2022, Published online: 26 Nov 2022

References

  • Masoli M, Fabian D, Holt S, et al. Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA dissemination committee report. Allergy. 2004;59(5):469–10.
  • GINA. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Date last accessed: September 13, 2020. <misc>Date last updated: 2020.
  • BTS/SIGN British guideline on the management of asthma, 2019. Date last accessed: May 4, 2020. Date last updated: 2020. Date last updated: 2019 May 4. Available from: https://www.brit-thoracic.org.uk/quality-improvement/guidelines/asthma/
  • Asthma. Current Care Guidelines. Working group set up by the Finnish Medical Society Duodecim, the Finnish Respiratory Society, the Finnish Paediatric Society, the Finnish Society of Clinical Physiology. Helsinki: The Finnish Medical Society Duodecim, 2022. Date last accessed: November 20, 2022. Date last updated: 2022. Date last accessed: https://www.kaypahoito.fi/hoi06030
  • Boulet L-B, Dorval E, Labrecque M, et al. Towards excellence in asthma management: final report of an eight-year program aimed at reducing care gaps in asthma management in Quebec. Can Respir J. 2008;15(6):302–310.
  • Haahtela T, Tuomisto, LE, Pietinalho, A , et al. A 10 year asthma programme in Finland: major change for the better. Thorax. 2006;61(8):663–670.
  • Woolcock A, Rubinfeld A, Seale P, et al. Asthma management plan, 1989. Med J Aust. 1989;151(11–12):650–653.
  • Haahtela T, Herse F, Karjalainen J, et al. The Finnish experience to save asthma costs by improving care in 1987-2013. J Allergy Clin Immunol. 2017;139(2):408–414.e2.
  • McCaul KA, Wakefield MA, Roder DM, et al. Trends in hospital readmission for asthma: has the Australian National Asthma campaign had an effect? Med J Aust. 2000;172(2):62–66.
  • Soto-Martínez M, Avila L, Soto N, et al. Trends in hospitalizations and mortality from asthma in CostaRica over a 12- to 15-year period. J Allergy Clin Immunol Pract. 2014;2(1):85–90.
  • Bateman ED, Boushey HA, Bousquet J, et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med. 2004;170(8):836–844.
  • FitzGerald JM, Boulet L-P, McIvor RA, et al. Asthma control in Canada remains suboptimal: the Reality of Asthma Control (TRAC) study. Can Respir J. 2006;13(5):253–259.
  • Price D, Fletcher M, van der Molen T. Asthma control and management in 8,000 European patients: the REcognise Asthma and LInk to symptoms and experience (REALISE) survey. npj Prim Care Respir Med. 2014;24(1):14009.
  • Murphy KR, Meltzer EO, Blaiss MS, et al. Asthma management and control in the USA: results of the 2009 Asthma Insight and Management survey. Allergy Asthma Proc. 2012;33(1):54–64.
  • Gold LS, Thompson P, Salvi S, et al. Level of asthma control and health care utilization in Asia-Pacific countries. Respir Med. 2014;108(2):271–277.
  • WHO Collaborating Centre for Drug Statistics Methodology, guidelines for ATC classification and DDD assignment 2020. Oslo: Norway, 2019. Date last accessed: Mar 15, 2020. Date last updated: 2020. Date last updated: 2020 Mar 15. Available from: https://www.whocc.no/filearchive/publications/2020_guidelines_web.pdf
  • Schatz M, Sorkness CA, Li JT, et al. Asthma control test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists. J Allergy Clin Immunol. 2006;117(3):549–556.
  • Weatherall M, Wijesinghe M, Perrin K, et al. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax. 2010;65(1):39–43.
  • Janson C, de Marco, R, Accordini, S, et al. Changes in the use of anti-asthmatic medication in an international cohort. Eur Respir J. 2005;26(6):1047–1055.
  • Reddel HK, Sawyer SM, Everett PW, et al. Asthma control in Australia: a cross-sectional web-based survey in a nationally representative population. Med J Aust. 2015;202(9):492–496.
  • Haahtela T, Klaukka, T, Koskela, K, et al. Asthma programme in Finland: a community problem needs community solutions. Thorax. 2001;56(10):806–814.
  • Kauppi P, Peura S, Salimäki J, et al. Reduced severity and improved control of self-reported asthma in Finland during 2001-2010. Asia Pac Allergy. 2015;5(1):32–39.
  • Takala J, Ilmarinen P, Tuomisto LE, et al. Planned primary health care asthma contacts during 12-year follow-up after Finnish national Asthma programme: focus on spirometry. npj Prim Care Respir Med. 2020;30(1):8.
  • Axelsson M, Ekerljung L, Lundbäck B. The significance of asthma follow-up consultations for adherence to asthma medication, asthma medication beliefs, and asthma control. Nurs Res Pract. 2015;2015:139070.
  • Yawn BP, Rank MA, Cabana MD, et al. Adherence to asthma guidelines in children, tweens, and adults in primary care settings: a practice-based network assessment. Mayo Clin Proc. 2016;91(4):411–421.
  • Royal College of Physicians. Why asthma still kills: the National Review of Asthma Deaths (NRAD) confidential enquiry report. London: RCP, 2014. Date last accessed: Apr 20, 2020. Date last updated: 2020. Date last updated: 2014 Apr 20. Available from: https://www.rcplondon.ac.uk/projects/outputs/why-asthma-still-kills.
  • Cazzoletti L, Marcon A, Janson C, et al. Asthma control in Europe: a real-world evaluation based on an international population-based study. J Allergy Clin Immunol. 2007;120(6):1360–1367.
  • Giraud V, Allaert F-A, Roche N. Inhaler technique and asthma: feasibility and acceptability of training by pharmacists. Respir Med. 2011;105(12):1815–1822.
  • Vervloet D, Williams AE, Lloyd A, et al. Costs of managing asthma as defined by a derived Asthma Control TestTM score in seven European countries. Eur Respir Rev. 2006;15(98):17–23.
  • Allegra L, Cremonesi G, Girbino G, et al. Real-life prospective study on asthma control in Italy: cross-sectional phase results. Respir Med. 2012;106(2):205–214.
  • Price DB, Rigazio A, Campbell JD, et al. Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study. Lancet Respir Med. 2015;3(11):849–858.
  • Kang H, Song HJ, Nam JH, et al. Risk factors of asthma exacerbation based on asthma severity: a nationwide population-based observational study in South Korea. BMJ Open. 2018;8(3):e020825.
  • Suruki RY, Daugherty JB, Boudiaf N, et al. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. BMC Pulm Med. 2017;17(1):74.
  • Kim J-L, Henneberger PK, Lohman S, et al. Impact of occupational exposures on exacerbation of asthma: a population-based asthma cohort study. BMC Pulm Med. 2016;16(1):148.
  • Ilmarinen P, Tuomisto LE, Niemelä O, et al. Prevalence of patients eligible for anti-IL-5 treatment in a cohort of adult-onset asthma. J Allergy Clin Immunol Pract. 2019;7(1):165–174.e4.
  • Watase H, Hagiwara Y, Chiba T, et al. Multicentre observational study of adults with asthma exacerbations: who are the frequent users of the emergency department in Japan? BMJ Open. 2015;5(4):e007435.
  • Vähätalo I, Ilmarinen P, Tuomisto LE, et al. 12-year adherence to inhaled corticosteroids in adult-onset asthma. ERJ Open Res. 2020;6(1):00324–2019.
  • Bloom CI, Palmer T, Feary J, et al. Exacerbation patterns in adults with asthma in England. A population-based study. Am J Respir Crit Care Med. 2019;199(4):446–453.
  • Alshabanat A, Zafari Z, Albanyan O, et al. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015;10:e0136065.